Published May 1, 2005 | Version v1
Journal article

Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways

  • 1. Department of Experimental Medicine and Pathology, Laboratory of Molecular Pathology, University 'La Sapienza', Viale Regina Elena, 324, 00161 Rome (Italy)
  • 2. Regina Elena Cancer Institute, Via Delle Messi d'Oro, 156, Rome 00158 (Italy)
  • 3. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104 (United States)
  • 4. Institute of Biochemistry University of Lausanne Chemin de Bovaresses 155 CH-1066 Epalinges (Switzerland)
  • 5. Neuromed Institute, Pozzilli (Italy)
  • 6. Department of Experimental Medicine and Pathology, Laboratory of Molecular Pathology, University 'La Sapienza', Viale Regina Elena, 324, 00161 Rome (Italy) and Istituto Pasteur-Fondazione Cenci Bolognetti, University 'La Sapienza', 00161 Roma (Italy)

Description

Notch signaling plays a key role in cell-fate determination and differentiation in different organisms and cell types. Several reports suggest that Notch signaling may be involved in neoplastic transformation. However, in primary keratinocytes, Notch1 can function as a tumor suppressor. Similarly, in HPV-positive cervical cancer cells, constitutively active Notch1 signaling was found to cause growth suppression. Activated Notch1 in these cells represses viral E6/E7 expression through AP-1 down-modulation, resulting in increased p53 expression and a block of pRb hyperphosphorylation. Here we show that in cervical cancer cell lines in which Notch1 ability to repress AP-1 activity is impaired, Notch1-enforced expression elicits an alternative pathway leading to growth arrest. Indeed, activated Notch1 signaling suppresses activity of the helix-loop-helix transcription factor E47, via ERK1/2 activation, resulting in inhibition of cell cycle progression. Moreover, we found that RBP-Jκ-dependent Notch signaling is specifically repressed in cervical cancer cells and this repression could provide one such mechanism that needs to be activated for cervical carcinogenesis. Finally, we show that inhibition of endogenous Notch1 signaling, although results in a proliferative advantage, sensitizes cervical cancer cell lines to drug-induced apoptosis. Together, our results provide novel molecular insights into Notch1-dependent growth inhibitory effects, counteracting the transforming potential of HPV

Additional details

Identifiers

DOI
10.1016/j.yexcr.2005.01.015;
PII
S0014-4827(05)00042-X;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
305
Journal Issue
2
Journal Page Range
p. 343-354
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
37029851
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANIMAL GROWTH; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; DRUGS; INHIBITION; NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFORMATIONS
Descriptors DEC
DISEASES; GROWTH; ORGANIC COMPOUNDS; PATHOGENESIS; PROTEINS

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.